{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000693,"version":"4.0.1"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12TR004411"],"award-info":[{"award-number":["K12TR004411"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1012575","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:24:04Z","timestamp":1727717044000},"page":"e1012575","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Put a little doxy-PEP in your step: Using doxycycline to prevent chlamydia, syphilis, and gonorrhea infections"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-6548","authenticated-orcid":true,"given":"Eric A.","family":"Meyerowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Mullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"Supplement 2","key":"ppat.1012575.ref001","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1097\/QAI.0b013e3182986f69","article-title":"Preexposure prophylaxis for HIV prevention: Where have we been and where are we going?","volume":"63","author":"JM Baeten","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"2","key":"ppat.1012575.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024.","volume":"73","author":"LH Bachmann","year":"2024","journal-title":"MMWR Recomm Rep."},{"issue":"14","key":"ppat.1012575.ref003","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"AF Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"ppat.1012575.ref004","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"JM Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ppat.1012575.ref005","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): A multicentre, open-label, randomised trial with a 2 \u00d7 2 factorial design.","author":"JM Molina","year":"2024","journal-title":"Lancet Infect Dis."},{"issue":"25","key":"ppat.1012575.ref006","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2304007","article-title":"Doxycycline prophylaxis to prevent sexually transmitted infections in women","volume":"389","author":"J Stewart","year":"2023","journal-title":"N Engl J Med"},{"key":"ppat.1012575.ref007","article-title":"Self-reported adherence to event-driven doxycycline postexposure prophylaxis for sexually transmitted infection prevention among cisgender women.","author":"J Stewart","year":"2023","journal-title":"STI and HIV World Congress."},{"issue":"13","key":"ppat.1012575.ref008","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMc2401273","volume":"390","author":"Doxycycline to prevent sexually transmitted infections in women","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"ppat.1012575.ref009","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/OLQ.0000000000001865","article-title":"Safety of longer-term doxycycline use: A systematic review and meta-analysis with implications for bacterial sexually transmitted infection chemoprophylaxis.","volume":"50","author":"PA Chan","year":"2023","journal-title":"Sexual Trans Dis."},{"key":"ppat.1012575.ref010","article-title":"Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections","volume":"ciad488","author":"MW Traeger","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ppat.1012575.ref011","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/09564624211042444","article-title":"Countering the rise of syphilis: A role for doxycycline post-exposure prophylaxis","volume":"33","author":"NK Tran","year":"2022","journal-title":"Int J STD AIDS"},{"key":"ppat.1012575.ref012","article-title":"Doxy-PEP associated with declines in chlamydia and syphilis in MSM and trans women in San Francisco [Abstract 127].","author":"M Sankaran","year":"2024","journal-title":"CROI"},{"issue":"4","key":"ppat.1012575.ref013","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/315372","article-title":"Multiple drug\u2013resistant Chlamydia trachomatis associated with clinical treatment failure","volume":"181","author":"J Somani","year":"2000","journal-title":"J Infect Dis"},{"issue":"4","key":"ppat.1012575.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021.","volume":"70","author":"KA Workowski","year":"2021","journal-title":"MMWR Recomm Rep."},{"issue":"22","key":"ppat.1012575.ref015","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMc2314441","article-title":"Near-universal tesistance to macrolides of Treponema pallidum in North America","volume":"390","author":"NAP Lieberman","year":"2024","journal-title":"N Engl J Med"},{"key":"ppat.1012575.ref016","article-title":"Doxycycline postexposure prophylaxis may delay seroconversion in incident syphilis.","author":"AR Raccagni","year":"2024","journal-title":"Sex Transm Infect."},{"key":"ppat.1012575.ref017","first-page":"100738","article-title":"Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: A population-based analysis","volume":"33","author":"PS Sullivan","year":"2024","journal-title":"Lancet Reg Health Am"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:24:08Z","timestamp":1727717048000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012575"}},"subtitle":[],"editor":[{"given":"Kimberly A.","family":"Kline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012575","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}